154 related articles for article (PubMed ID: 29392699)
21. Antitumor compound testing in glioblastoma organotypic brain cultures.
Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
[TBL] [Abstract][Full Text] [Related]
22. Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation.
Yoo KC; Suh Y; An Y; Lee HJ; Jeong YJ; Uddin N; Cui YH; Roh TH; Shim JK; Chang JH; Park JB; Kim MJ; Kim IG; Kang SG; Lee SJ
Oncogene; 2018 Jun; 37(24):3317-3328. PubMed ID: 29559744
[TBL] [Abstract][Full Text] [Related]
23. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.
Dahan P; Martinez Gala J; Delmas C; Monferran S; Malric L; Zentkowski D; Lubrano V; Toulas C; Cohen-Jonathan Moyal E; Lemarie A
Cell Death Dis; 2014 Nov; 5(11):e1543. PubMed ID: 25429620
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
[TBL] [Abstract][Full Text] [Related]
25. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?
Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Dühmke E; Hofstetter A
Curr Med Chem; 2005; 12(10):1209-15. PubMed ID: 15892632
[TBL] [Abstract][Full Text] [Related]
26. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme.
Zhou H; Miki R; Eeva M; Fike FM; Seligson D; Yang L; Yoshimura A; Teitell MA; Jamieson CA; Cacalano NA
Clin Cancer Res; 2007 Apr; 13(8):2344-53. PubMed ID: 17438093
[TBL] [Abstract][Full Text] [Related]
29. A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs.
Parker JJ; Lizarraga M; Waziri A; Foshay KM
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28784966
[TBL] [Abstract][Full Text] [Related]
30. RAD18 mediates resistance to ionizing radiation in human glioma cells.
Xie C; Wang H; Cheng H; Li J; Wang Z; Yue W
Biochem Biophys Res Commun; 2014 Feb; 445(1):263-8. PubMed ID: 24518219
[TBL] [Abstract][Full Text] [Related]
31. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
[TBL] [Abstract][Full Text] [Related]
32. Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol.
Komorowska D; Radzik T; Kalenik S; Rodacka A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142554
[TBL] [Abstract][Full Text] [Related]
33. Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.
Vecchio D; Daga A; Carra E; Marubbi D; Baio G; Neumaier CE; Vagge S; Corvò R; Pia Brisigotti M; Louis Ravetti J; Zunino A; Poggi A; Mascelli S; Raso A; Frosina G
Int J Cancer; 2014 Jul; 135(2):479-91. PubMed ID: 24443327
[TBL] [Abstract][Full Text] [Related]
34. Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.
Yount G; Qian Y; Moore D; Basila D; West J; Aldape K; Arvold N; Shalev N; Haas-Kogan D
J Exp Ther Oncol; 2004 Jul; 4(2):137-43. PubMed ID: 15500008
[TBL] [Abstract][Full Text] [Related]
35. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
36. Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma.
Ruiz-Garcia H; Ramirez-Loera C; Malouff TD; Seneviratne DS; Palmer JD; Trifiletti DM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575840
[TBL] [Abstract][Full Text] [Related]
37. Astrocytes, the rising stars of the glioblastoma microenvironment.
Brandao M; Simon T; Critchley G; Giamas G
Glia; 2019 May; 67(5):779-790. PubMed ID: 30240060
[TBL] [Abstract][Full Text] [Related]
38. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture.
Tribius S; Pidel A; Casper D
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):511-23. PubMed ID: 11380241
[TBL] [Abstract][Full Text] [Related]
39. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
van Nifterik KA; van den Berg J; Stalpers LJ; Lafleur MV; Leenstra S; Slotman BJ; Hulsebos TJ; Sminia P
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1246-53. PubMed ID: 17967314
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells in vitro.
Storch K; Sagerer A; Cordes N
Oncol Rep; 2015 Apr; 33(4):2009-16. PubMed ID: 25625667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
